HMGA2 promotes nasopharyngeal carcinoma progression and is associated with tumor resistance and poor prognosis

被引:2
|
作者
Ouyang, Xinting [1 ]
Li, Kangxin [1 ]
Wang, Jiaqi [1 ]
Zhu, Weijian [1 ]
Yi, Qiang [1 ]
Zhong, Jinghua [2 ]
机构
[1] Gannan Med Univ, Ganzhou, Jiangxi, Peoples R China
[2] Gannan Med Univ, Affiliated Hosp 1, Dept Oncol, Ganzhou, Jiangxi, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2024年 / 13卷
基金
中国国家自然科学基金;
关键词
nasopharyngeal carcinoma; HMGA2; invasion metastasis; tumor resistance; prognosis; EPITHELIAL-MESENCHYMAL TRANSITION; GROUP-A PROTEINS; TRANSCRIPTIONAL ACTIVATION; E-CADHERIN; CANCER; AUTOPHAGY; STEM; GENE; EMT; EXPRESSION;
D O I
10.3389/fonc.2023.1271080
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Nasopharyngeal carcinoma (NPC), as one of the most prevalent malignancies in the head and neck region, still lacks a complete understanding of its pathogenesis. Presently, radiotherapy, concurrent chemoradiotherapy, and targeted therapy stand as the primary modalities for treating NPC. With advancements in medicine, the cure rates for nasopharyngeal carcinoma have been steadily increasing. Nevertheless, recurrence and metastasis persist as the primary reasons for treatment failure. Consequently, a profound exploration of the molecular mechanisms underlying the occurrence and progression of nasopharyngeal carcinoma, along with the exploration of corresponding therapeutic approaches, becomes particularly imperative in the quest for comprehensive solutions to combat this disease. High mobility group AT-hook 2 (HMGA2) is a pivotal protein capable of altering chromatin structure, regulating gene expression, and influencing transcriptional activity. In the realm of cancer research, HMGA2 exhibits widespread dysregulation, playing a crucial role in nearly all malignant tumors. It is implicated in various tumorigenic processes, including cell cycle regulation, cell proliferation, epithelial-mesenchymal transition, angiogenesis, tumor invasion, metastasis, and drug resistance. Additionally, HMGA2 serves as a molecular marker and an independent prognostic factor in certain malignancies. Recent studies have increasingly unveiled the critical role of HMGA2 in nasopharyngeal carcinoma (NPC), particularly in promoting malignant progression, correlating with tumor resistance, and serving as an independent adverse prognostic factor. This review focuses on elucidating the oncogenic role of HMGA2 in NPC, suggesting its potential association with chemotherapy resistance in NPC, and proposing its candidacy as an independent factor in nasopharyngeal carcinoma prognosis assessment.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] HMGA2 is associated with epithelial-mesenchymal transition and can predict poor prognosis in nasopharyngeal carcinoma
    Xia, You-You
    Yin, Li
    Tian, Hao
    Guo, Wen-Jie
    Jiang, Ning
    Jiang, Xue-Song
    Wu, Jing
    Chen, Meng
    Wu, Jian-Zhong
    He, Xia
    ONCOTARGETS AND THERAPY, 2014, 8 : 169 - 176
  • [2] Hornerin promotes tumor progression and is associated with poor prognosis in hepatocellular carcinoma
    Fu, Shun-Jun
    Shen, Shun-Li
    Li, Shao-Qiang
    Hua, Yun-Peng
    Hu, Wen-Jie
    Guo, BeiChu
    Peng, Bao-Gang
    BMC CANCER, 2018, 18
  • [3] Hornerin promotes tumor progression and is associated with poor prognosis in hepatocellular carcinoma
    Shun-Jun Fu
    Shun-Li Shen
    Shao-Qiang Li
    Yun-Peng Hua
    Wen-Jie Hu
    BeiChu Guo
    Bao-Gang Peng
    BMC Cancer, 18
  • [4] Foxj2 overexpression is associated with poor prognosis, progression, and metastasis in nasopharyngeal carcinoma
    Shan, Ying
    Chang, Tao
    Shi, Si
    Tang, Mingming
    Bao, Lili
    Li, Li
    You, Bo
    You, Yiwen
    ONCOTARGETS AND THERAPY, 2017, 10 : 3733 - 3741
  • [5] HMGA2 promotes glioma invasion and poor prognosis via a long-range chromatin interaction
    Zhang, Shanshan
    Zhang, Huibian
    Yu, Lin
    CANCER MEDICINE, 2018, 7 (07): : 3226 - 3239
  • [6] Transcriptome Profiling Identifies HMGA2 as a Biomarker of Melanoma Progression and Prognosis
    Raskin, Leon
    Fullen, Douglas R.
    Giordano, Thomas J.
    Thomas, Dafydd G.
    Frohm, Marcus L.
    Cha, Kelly B.
    Ahn, Jaeil
    Mukherjee, Bhramar
    Johnson, Timothy M.
    Gruber, Stephen B.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2013, 133 (11) : 2585 - 2592
  • [7] HMGA2 Contributes to Distant Metastasis and Poor Prognosis by Promoting Angiogenesis in Oral Squamous Cell Carcinoma
    Sakata, Junki
    Hirosue, Akiyuki
    Yoshida, Ryoji
    Kawahara, Kenta
    Matsuoka, Yuichiro
    Yamamoto, Tatsuro
    Nakamoto, Masafumi
    Hirayama, Masatoshi
    Takahashi, Nozomu
    Nakamura, Takuya
    Arita, Hidetaka
    Nakashima, Hikaru
    Nagata, Masashi
    Hiraki, Akimitsu
    Shinohara, Masanori
    Nakayama, Hideki
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (10)
  • [8] Versican Promotes Tumor Progression, Metastasis and Predicts Poor Prognosis in Renal Carcinoma
    Mitsui, Yozo
    Shiina, Hiroaki
    Kato, Taku
    Maekawa, Shigekatsu
    Hashimoto, Yutaka
    Shiina, Marisa
    Imai-Sumida, Mitsuho
    Kulkarni, Priyanka
    Dasgupta, Pritha
    Wong, Ryan Kenji
    Hiraki, Miho
    Arichi, Naoko
    Fukuhara, Shinichiro
    Yamamura, Soichiro
    Majid, Shahana
    Saini, Sharanjot
    Deng, Guoren
    Dahiya, Rajvir
    Nakajima, Koichi
    Tanaka, Yuichiro
    MOLECULAR CANCER RESEARCH, 2017, 15 (07) : 884 - 895
  • [9] HMGA2 promotes vasculogenic mimicry and tumor aggressiveness by upregulating Twist1 in gastric carcinoma
    Junying Sun
    Baocun Sun
    Ran Sun
    Dongwang Zhu
    Xiulan Zhao
    Yanhui Zhang
    Xueyi Dong
    Na Che
    Jing Li
    Fang Liu
    Nan Zhao
    Yong Wang
    Danfang Zhang
    Scientific Reports, 7
  • [10] Increased expression of CD55 correlates with tumor progression and poor prognosis in nasopharyngeal carcinoma
    Shen, Yumei
    Yin, Ruixue
    Deng, Xiaogang
    Shen, Hong
    CLINICAL AND INVESTIGATIVE MEDICINE, 2012, 35 (01): : E34 - E39